GlucoTrack Statistics
Want to see GCTK full AI Analyst Report?
GlucoTrack (GCTK) Stock Statistics & Valuation Metrics
Total Valuation
GlucoTrack has a market cap or net worth of $284.19K. The enterprise value is $2.43M.
- Market Cap
- $284.19K
- Enterprise Value
- $2.43M
Share Statistics
GlucoTrack has 1,184,118 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,184,118
- Owned by Insiders
- ―
- Owned by Institutions
- <0.01%
Financial Efficiency
GlucoTrack’s return on equity (ROE) is -6.86 and return on invested capital (ROIC) is -520.21%.
- Return on Equity (ROE)
- -6.86
- Return on Assets (ROA)
- -2.47
- Return on Invested Capital (ROIC)
- -520.21%
- Return on Capital Employed (ROCE)
- -5.25
- Revenue Per Employee
- 0
- Profits Per Employee
- -1.29M
- Employee Count
- 15
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of GlucoTrack is -0.00. GlucoTrack’s PEG ratio is -0.00.
- PE Ratio
- -0.00
- PS Ratio
- 0.00
- PB Ratio
- -0.03
- Price to FCF
- -0.01
- Price to Operating Cash Flow
- -0.00
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, GlucoTrack had revenue of 0 and earned -19.39M in profits. Earnings per share was -646.80.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -16.09M
- Pretax Income
- -19.39M
- Net Income
- -19.39M
- EBITDA
- -19.35M
- Earnings Per Share (EPS)
- -646.80
Cash Flow
In the last 12 months, operating cash flow was -16.22M and capital expenditures -87,000, giving a free cash flow of -16.31M billion.
- Operating Cash Flow
- -16.22M
- Free Cash Flow
- -16.31M
- Free Cash Flow per Share
- -146.79
Dividends & Yields
GlucoTrack pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -9081.09%
- Earnings Yield
- -31898.05%
Stock Price Statistics
- Beta
- 2.92
- 52-Week Price Change
- -99.87%
- 50-Day Moving Average
- 2.81
- 200-Day Moving Average
- 17.54
- Relative Strength Index (RSI)
- 28.02
- Average Volume (3m)
- 1.84M
Important Dates
GlucoTrack upcoming earnings date is Apr 05, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 12, 2026
- Next Earnings Date
- Apr 05, 2027
- Ex-Dividend Date
- ―
Financial Position
GlucoTrack as a current ratio of 1.61, with Debt / Equity ratio of 1.17%
- Current Ratio
- 1.61
- Quick Ratio
- 1.61
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- 0.38
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, GlucoTrack has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
GlucoTrack EV to EBITDA ratio is 0.06, with an EV/FCF ratio of 0.06.
- EV to Sales
- 0.00
- EV to EBITDA
- 0.06
- EV to Free Cash Flow
- 0.06
- EV to Operating Cash Flow
- 0.06
Balance Sheet
GlucoTrack has $1.12M in cash and marketable securities with $19.00K in debt, giving a net cash position of $1.10M billion.
- Cash & Marketable Securities
- $1.12M
- Total Debt
- $19.00K
- Net Cash
- $1.10M
- Net Cash Per Share
- $0.93
- Tangible Book Value Per Share
- -$15.67
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for GlucoTrack is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 99.51%
Scores
- Smart Score
- ―
- AI Score
- 39
